Corbus Pharmaceuticals, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 29
Rang # Quantité totale PI 49 797
Note d'activité PI 2/5.0    16
Rang # Activité PI 52 942
Parent Corbus Pharmaceuticals Holdings, Inc
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

7 3
2 3
12 2
0
 
Dernier brevet 2023 - Compositions of ajulemic acid an...
Premier brevet 2009 - 8-tetrahydrocannabinol-11-oic acids
Dernière marque 2017 - EMPRELVIA
Première marque 2015 - CORBUS PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof. Disclosed herein are compou...
2021 Invention Ultrapure tetrahydrocannabinol-11-oic acids. This application is in the field of medicinal chemi...
2020 Invention Cannabinoids and uses thereof. The invention relates to cannabinoid compounds, pharmaceutical com...
Invention Compositions of ajulemic acid and uses thereof. The invention relates to crystalline forms of (6...
Invention Compositions of ajulemic acid and uses thereof. The invention relates to crystalline forms of (6a...
Invention Compositions of ajulemic acid and uses thereof. RRHH-benzo[c]chromene-9-carboxylic acid (ajulemic...
Invention Compositions and methods for attenuating side effects of immune checkpoint inhibitor therapy. Dis...
Invention Methods for the treatment of infection. The invention provides methods for treating an infection...
2019 Invention Lipoxin a4 analogs and uses thereof. The invention relates to (S)-6-((1 R,2E,4E,8E,10S)-11-(4-fl...
Invention Lipoxin a4 analogs and uses thereof. REEES444). In particular, the invention features pharmaceuti...
Invention Cannabinoids and uses thereof. The invention relates to cannabinoid compounds, pharmaceutical co...
Invention Ultrapure tetrahydrocannabinol-11-oic acids. This application is in the field of medicinal chemis...
2018 Invention Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol. The invention ...
Invention Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol. The invention p...
2017 P/S Pharmaceutical products for the treatment of fibrosis and inflammatory diseases, namely, cystic f...
Invention Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids. This invention is...
Invention Methods for the treatment of infection. The invention provides methods for treating an infection ...
2016 Invention Compositions, dosages, and methods of using tetrahydrocannabinol derivatives. Dosage forms of c...
P/S Pharmaceutical products for the treatment of fibrosis and inflammation diseases, namely, cystic f...
P/S Pharmaceutical preparations for the treatment of inflammatory and fibrotic diseases, namely, cyst...
P/S Pharmaceutical preparations. Distribution of medical information.
P/S Pharmaceutical products for the treatment of fibrosis and inflammation. Distribution of medical ...
2015 P/S Providing personalized healthcare and medical information in the area of fibrosis and inflammation
P/S Pharmaceutical preparations for the treatment of fibrosis and inflammation
P/S Distribution of medical information by providing a website featuring information about pharmaceut...
2011 Invention Compositions, dosages, and methods of using tetrahydrocannabinol derivatives. Dosage forms of co...
2009 Invention 8-tetrahydrocannabinol-11-oic acids. 8-THC-11-oic acids, for treatment of interstitial cystitis i...